The promise of Donanemab: a new hope in the fight against Alzheimer’s
The Phase 3 study of donanemab has yielded encouraging outcomes, representing a notable advancement in the fight against Alzheimer's disease.
Lisa Genova: communicating science, one novel at a time
Lisa Genova's writings — including books like ‘Still Alice’ — give a voice to individuals who are battling chronic diseases like Alzheimer’s.
Podcast Transcript — Episode 43: Catastrophic Brain Bleeds (Part 3)
Drs. Ayesha and Dean Sherzai take a deep dive into the topic of brain bleeds and hemorrhagic strokes. Read the full transcript.